Free Trial

Sarepta Therapeutics (SRPT) News Today

→ No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (From Hedgeye) (Ad)
Free SRPT Stock Alerts
$123.32
+5.88 (+5.01%)
(As of 06/7/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends
June 7 at 1:19 PM | marketbeat.com
Sarepta Therapeutics (NASDAQ:SRPT) Trading Up 4.1%
Sarepta Therapeutics (NASDAQ:SRPT) Trading 4.1% Higher
June 7 at 5:01 AM | marketbeat.com
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Shares Bought by Hsbc Holdings PLC
Hsbc Holdings PLC lifted its position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 1,033.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 28,513 shares of the biotechnology compan
June 6 at 7:00 AM | investorplace.com
Exit Strategy: 3 Overvalued Stocks to Sell Before They Deflate
June 5 at 3:32 PM | marketbeat.com
Capital International Investors Purchases 2,917,797 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Capital International Investors lifted its position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 160.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,741,485 shares of
June 2, 2024 | marketbeat.com
Alpha DNA Investment Management LLC Purchases Shares of 5,832 Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Alpha DNA Investment Management LLC purchased a new stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 5,832 shares of the biotechnology company's stock,
May 31, 2024 | businesswire.com
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 31, 2024 | americanbankingnews.com
Sarepta Therapeutics (NASDAQ:SRPT) Earns Overweight Rating from Analysts at Piper Sandler
May 31, 2024 | marketbeat.com
Principal Financial Group Inc. Acquires 27,549 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Principal Financial Group Inc. raised its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 125.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 49,539 shares of the biotech
May 30, 2024 | marketbeat.com
Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Up to $116.25
Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Up to $116.25
May 29, 2024 | ca.finance.yahoo.com
I:RUT Oct 2024 Weekly 2200.000
May 29, 2024 | ca.finance.yahoo.com
I:RUT Jun 2024 Weekly 1685.000
May 29, 2024 | msn.com
With FDA Decision Date Approaching, Analyst Downgrades Sarepta On Balanced Risk And Reward
May 29, 2024 | finance.yahoo.com
Is Sarepta Therapeutics, Inc. (NASDAQ:SRPT) A Good Fast Growth Stock To Buy?
May 29, 2024 | marketbeat.com
UBS Group AG Acquires 57,805 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
UBS Group AG raised its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 26.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 276,276 shares of the biotechnology company's stock after pu
May 29, 2024 | americanbankingnews.com
Sarepta Therapeutics (NASDAQ:SRPT) Receives Sector Perform Rating from Royal Bank of Canada
May 28, 2024 | msn.com
RBC Capital cuts Sarepta to sector perform ahead of FDA decision
May 28, 2024 | msn.com
RBC Capital Downgrades Sarepta Therapeutics (SRPT)
May 28, 2024 | msn.com
Sarepta Downgraded As FDA Decision Date Approaches, Shares Up 50% Over Last Six Months
May 28, 2024 | marketbeat.com
Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Down to $123.46
Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Down to $123.46
May 28, 2024 | marketbeat.com
Sarepta Therapeutics (NASDAQ:SRPT) Given Sector Perform Rating at Royal Bank of Canada
Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $142.00 price target (down previously from $157.00) on shares of Sarepta Therapeutics in a report on Tuesday.
May 28, 2024 | ca.finance.yahoo.com
SRPT Jun 2024 143.000 call
May 26, 2024 | marketbeat.com
836,849 Shares in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Bought by Norges Bank
Norges Bank purchased a new stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund purchased 836,849 shares of the biotechnology company's stock, valued at approximately $80,697,000. Norges Bank owned abo
May 25, 2024 | marketbeat.com
Clearbridge Investments LLC Buys New Shares in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Clearbridge Investments LLC purchased a new position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 151,127 shares of the biotechnology company's stock, valued at approximately $14,573,0
May 24, 2024 | benzinga.com
Decoding Sarepta Therapeutics's Options Activity: What's the Big Picture?
May 24, 2024 | finance.yahoo.com
Implied Volatility Surging for Sarepta (SRPT) Stock Options
May 23, 2024 | investorplace.com
The 2030 Millionaire's Club: 3 Biotech Stocks to Buy Now
May 22, 2024 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH) and Sarepta Therapeutics (SRPT)
May 22, 2024 | marketbeat.com
67,433 Shares in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Bought by Trexquant Investment LP
Trexquant Investment LP acquired a new position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 67,433 shares of the biotechnol
May 22, 2024 | benzinga.com
Jim Cramer: This Industrial Stock Is Doing 'Very Well'; Here's His Take On Palantir
May 21, 2024 | marketbeat.com
Traders Buy High Volume of Sarepta Therapeutics Call Options (NASDAQ:SRPT)
Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Get Free Report) was the recipient of some unusual options trading activity on Tuesday. Stock traders purchased 3,559 call options on the company. This represents an increase of 71% compared to the average daily volume of 2,081 call options.
May 20, 2024 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and Sol-Gel Technologies (SLGL)
May 20, 2024 | markets.businessinsider.com
12 Analysts Have This To Say About Sarepta Therapeutics
May 20, 2024 | marketbeat.com
Sarepta Therapeutics (NASDAQ:SRPT) Rating Reiterated by Needham & Company LLC
Needham & Company LLC reiterated a "buy" rating and set a $166.00 price objective on shares of Sarepta Therapeutics in a report on Monday.
May 19, 2024 | marketbeat.com
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Stake Lifted by Mizuho Markets Americas LLC
Mizuho Markets Americas LLC increased its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 24.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30
May 17, 2024 | markets.businessinsider.com
Buy Rating for Sarepta Therapeutics’ Elevidys Supported by Positive Regulatory Signals
May 17, 2024 | marketbeat.com
Thornburg Investment Management Inc. Grows Stock Position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Thornburg Investment Management Inc. increased its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 138.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 40,345 shares of the biotechnolo
May 17, 2024 | marketbeat.com
Sarepta Therapeutics (NASDAQ:SRPT) PT Raised to $179.00 at Mizuho
Mizuho lifted their price target on shares of Sarepta Therapeutics from $145.00 to $179.00 and gave the company a "buy" rating in a research note on Friday.
May 17, 2024 | marketbeat.com
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Shares Sold by Fiera Capital Corp
Fiera Capital Corp cut its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 2.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 348,212 shares of the biotechnology company's stock after selling 8,111 shares duri
May 15, 2024 | marketbeat.com
203,882 Shares in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Bought by First Turn Management LLC
First Turn Management LLC bought a new stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 203,882 shares of the biotechnology company's stock, v
May 14, 2024 | marketbeat.com
Nicholas Investment Partners LP Sells 2,084,756 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Nicholas Investment Partners LP lessened its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 99.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,329 shares of the biotechnology company
May 14, 2024 | msn.com
Roblox downgraded, Western Digital initiated: Wall Street's top analyst calls
May 14, 2024 | msn.com
Oppenheimer Upgrades Sarepta Therapeutics (SRPT)
May 14, 2024 | msn.com
Sarepta upgraded at Oppenheimer on potential Elevidys label expansion
May 14, 2024 | marketbeat.com
Oppenheimer Upgrades Sarepta Therapeutics (NASDAQ:SRPT) to "Outperform"
Oppenheimer raised shares of Sarepta Therapeutics from a "market perform" rating to an "outperform" rating and set a $180.00 target price on the stock in a research note on Tuesday.
May 11, 2024 | marketbeat.com
Swiss National Bank Sells 17,800 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Swiss National Bank lowered its stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 10.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 156,283 shares of the biotechnology company's stock af
May 7, 2024 | insidertrades.com
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Insider Dallan Murray Sells 3,635 Shares
May 6, 2024 | marketbeat.com
Insider Selling: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Insider Sells 3,635 Shares of Stock
Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Get Free Report) insider Dallan Murray sold 3,635 shares of the business's stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $140.00, for a total value of $508,900.00. Following the completion of the sale, the insider now owns 18,125 shares in the company, valued at $2,537,500. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
May 5, 2024 | marketbeat.com
10,146 Shares in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Acquired by Sapient Capital LLC
Sapient Capital LLC purchased a new stake in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 10,146 shares of the biotechnology company's stock,
May 5, 2024 | finance.yahoo.com
Earnings Beat: Sarepta Therapeutics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
May 4, 2024 | investorplace.com
3 Biotech Stocks With the Potential to Make You an Overnight Millionaire
Get Sarepta Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRPT and its competitors with MarketBeat's FREE daily newsletter.

Top 5 AI Stocks to Buy for 2024 (Ad)

The electric vehicle boom is accelerating – and fast.

Click to View The 5 Best AI Stocks to Invest In

SRPT Media Mentions By Week

SRPT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SRPT
News Sentiment
▼
0.77

0.73
▲
Average
Medical
News Sentiment

SRPT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SRPT Articles
This Week
▼
5

9
▲
SRPT Articles
Average Week

Get Sarepta Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRPT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:SRPT) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners
Millionaire-Making “Wealth Pattern” Just Repeated on April 22
If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.
Paradigm Press | Sponsored
Breaking - The US Gov. Seized CITGO
Do you want an investment that can double or triple your money in the next three months? The US Court is cu...
Augury Research | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
AI Hell Will Break Loose [June 30, 2024] …
On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...
Banyan Hill Publishing | Sponsored
Was the Great Financial Crisis fun?
The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...
Brooks Enterprises | Sponsored
Shocking $16T Elon Musk Crypto Leak
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...
Crypto 101 Media | Sponsored